Resources.
The Pretty Equity Decision Briefs are practical reference tools for investors and founders navigating compliance, diligence, and scale in beauty and personal care. Each brief addresses a specific area of risk that most pitch decks don't cover. All are free with email.
MoCRA
What It Requires, What It Means, and What You Must Have in Place
The most significant expansion of FDA authority over cosmetics since 1938. Most brands are still catching up.
This plain-language guide covers every MoCRA requirement now in effect—facility registration, product listing, safety substantiation, adverse event reporting, and GMP—and what each one means for investors evaluating beauty brands and founders building them.
Due Diligence
The Beauty Investor Due Diligence Questionnaire
Most beauty due diligence stops at the financials. The operational and regulatory risks that determine whether a brand can scale, survive a recall, or hold up under scrutiny rarely make it into the standard process.
This questionnaire surfaces those risks across nine categories: regulatory compliance, safety and testing, documentation, manufacturing, supply chain, claims defensibility, financials, scale readiness, and known risks.
The Basics
The 7 Questions Every Beauty Investor Must Ask
Before the term sheet. Before the wire. Before it's too late.
Beauty investing looks approachable. What doesn't show up in the pitch deck is the operational and regulatory complexity underneath — the classification errors, the documentation gaps, the supply chain assumptions that hold until they don't. This brief covers the 7 questions designed to surface the risks most diligence processes miss.
All briefs are free and delivered by email. No spam. No hype. Just clarity.
Inquiries: insights@prettyequity.com